N-(Benzylsulfonyl)-1-(3-cyano-5-oxo-6,7-dihydro-5H-pyrrolo-[3,4-b]pyridin-2-yl)piperidine-4-carboxamide

ID: ALA5286497

Max Phase: Preclinical

Molecular Formula: C21H21N5O4S

Molecular Weight: 439.50

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1cc2c(nc1N1CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC1)CNC2=O

Standard InChI:  InChI=1S/C21H21N5O4S/c22-11-16-10-17-18(12-23-21(17)28)24-19(16)26-8-6-15(7-9-26)20(27)25-31(29,30)13-14-4-2-1-3-5-14/h1-5,10,15H,6-9,12-13H2,(H,23,28)(H,25,27)

Standard InChI Key:  JRKMDCOUGBAABY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   39.7947  -13.4465    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.3903  -12.7408    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   38.9813  -13.4439    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4414  -11.5135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1511  -11.1041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1483  -10.2814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4397   -9.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8572  -11.5108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8565  -12.3289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5608  -12.7363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2702  -12.3301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2709  -11.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5621  -11.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8522   -9.8690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5584   -9.4577    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9770  -12.7402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9752  -13.5574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.6857  -12.3332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.1011  -12.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8079  -12.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8014  -13.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5073  -13.9732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2169  -13.5661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2161  -12.7447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5095  -12.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7309  -11.1063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7375  -10.2850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9585  -10.0248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4703  -10.6854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9477  -11.3537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7123   -9.2456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
 26  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7 27  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  5  8  1  0
 14 15  3  0
  6 14  1  0
 11 16  1  0
 16 17  2  0
 16 18  1  0
 18  2  1  0
  2 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
 28 31  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5286497

    ---

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.50Molecular Weight (Monoisotopic): 439.1314AlogP: 1.06#Rotatable Bonds: 5
Polar Surface Area: 132.26Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.98CX Basic pKa: 1.34CX LogP: 0.85CX LogD: -0.09
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.71Np Likeness Score: -1.32

References

1. Kong D, Xue T, Guo B, Cheng J, Liu S, Wei J, Lu Z, Liu H, Gong G, Lan T, Hu W, Hu W, Yang Y..  (2019)  Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties.,  62  (6.0): [PMID:30843696] [10.1021/acs.jmedchem.8b01971]

Source